US Patent
US9744207 — Pharmaceutical compositions with enhanced stability
Formulation · Assigned to Foresee Pharmaceuticals Co Ltd · Expires 2027-01-16 · 1y remaining
Vulnerability score
60/100
Moderate — design-around opportunities exist
What this patent protects
This patent protects a stabilized biodegradable polymeric composition for controlled release delivery of peptide agents, such as LHRH analogs.
USPTO Abstract
The present invention provides for a stabilized biodegradable polymeric composition useful as a controlled release delivery system for peptide agents. The compositions of the present invention comprise a) a beneficial salt of a luteinizing hormone releasing hormone (LHRH) analog formed with a strong acid that minimizes or prevents the interaction/reaction between the LHRH and the polymer in an organic solution; b) a biodegradable polymer; c) a pharmaceutically acceptable organic solvent; and d) optionally one or more excipients. The present invention also relates to a method of manufacturing and a method of use thereof.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.